Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Friday, July 17, 1998 Published at 06:53 GMT 07:53 UK


World: Americas

Fresh start for notorious drug

Scientists carry out a thalidomide experiment

One of the world's most notorious drugs, thalidomide, has been approved for sale again in the United States.

The drug will be used for the treatment of leprosy and is expected to be issued to 50 patients per year.


BBC Washington correspondent Paul Reynolds: "Black market"
Thalidomide, originally used as a sedative for pregnant women, was banned worldwide more than 30 years ago after it caused horrific defects in thousands of babies.

Severe restrictions will be put on the drug's use, and patients will be expected to follow a strict birth control regime while using it.

But the BBC's Washington correspondent says there are fears that the drug will reach a wider population. It has already appeared on the black market in Mexico.

Strict conditions

The US Food and Drug Administration approved the drug's sale for use in treating erythema nodosum leprosum, a painful, debilitating condition.

An FDA statement said: "Because of its well-known potential for causing birth defects, thalidomide will be among the most tightly restricted drugs ever to be marketed in the United States."


[ image: A 'thalidomide baby' with prosthetic arms]
A 'thalidomide baby' with prosthetic arms
Thalidomide manufacturer, the Celgene Corporation, said precautions are in place to ensure the drug is not taken by pregnant women.

Female patients will be required to use two forms of birth control while taking the drug and have regular pregnancy tests.

Men using the drug will be required to use condoms during sex.

Before a prescription is issued, a copy of an informed consent form must be presented at the pharmacy. Prescriptions will be for 28 days, with no automatic renewals.

Celgene began developing the drug for Aids-related, dermatological and cancer-related conditions in 1992.





Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©




Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia


Internet Links

The Leprosy Mission

FDA Thalidomide Information

Thalidomide Victims Association of Canada


The BBC is not responsible for the content of external internet sites.




In this section

From Business
Microsoft trial mediator appointed

Safety chief deplores crash speculation

From Entertainment
Taxman scoops a million

Violence greets Clinton visit

Bush outlines foreign policy

Boy held after US school shooting

Memorial for bonfire dead

Senate passes US budget

New constitution for Venezuela

North Korea expels US 'spy'

Hurricane Lenny abates

UN welcomes US paying dues

Chavez praises 'advanced' constitution

In pictures: Castro strikes out Chavez

WTO: arbitration in EU-Ecuador banana dispute

Colombian army chief says rebels defeated

Colombian president lambasts rebels